CDK4 and sarcoma: L-type sarcomas (ie, leiomyosarcoma, liposarcoma) constituted the greatest proportion of cases, and this is indicative by the preponderance of TP53, RB1 alterations and MDM2 and CDK4 amplifications (Table 3).